Epitomics enter support agreement for antibody technology Epitomics.

Bayer, Epitomics enter support agreement for antibody technology Epitomics, Inc ed treatment here . Announced today that it offers signed a service contract with Bayer Schering Pharma AG, Germany . Epitomics use its proprietary rabbit monoclonal antibody technology to create antibodies for Bayer HealthCare’s drug focus on identification and validation. Epitomics has already established a long-standing encounter with Bayer Health care. This new contract is a major growth of our collaboration and confirms the achievement of our high quality technology system, said Guo-Liang Yu, PhD, CEO of Epitomics, Inc. Our recent encounter with the Epitomics rabbit antibody technology provides been amazing and we have become pleased to be growing our collaboration with Epitomics, said Clive R.


If it takes place in a coronary artery, it could lead to severe coronary syndrome , a complication of cardiovascular system disease which include conditions such as for example myocardial infarction and unstable angina. VAT is in charge of significant mortality and morbidity, and requires energetic or preventative treatment in order to avoid potentially significant or fatal individual outcomes. About Bayer Health care The Bayer Group can be a worldwide enterprise with primary competencies in the areas of healthcare, agriculture and high-tech components.

Other Posts From Category "medicine":

Related Posts